Pfizer (China)

Recent papers from Pfizer (China)

1. A phase 3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of zavegepant for the acute treatment of migraine in Asian adultsThe Journal of Headache and Pain · 2026
2. Invasive Pneumococcal Disease in Children: A Retrospective Three-Center Study in Zhejiang Province, China (2010–2024)Infectious Diseases and Therapy · 2026
3. Lung cancer multidisciplinary care status and evidence-practice gap: a scoping review protocolBMJ Open · 2026
4. Clostridioides difficile Infection (CDI) Disease Burden (Cases, Hospitalizations, and Deaths) in Mainland China: A Systematic Literature ReviewInfectious Disease Reports · 2026
5. Pharmacokinetics and pharmacodynamics of cefoperazone/sulbactam in neutropenic murine lung and thigh infection models against Gram-negative organismsJournal of Antimicrobial Chemotherapy · 2026
6. Effect of esomeprazole on the pharmacokinetics of vepdegestrant, a PROteolysis TArgeting Chimera oestrogen receptor degrader, in healthy participantsBritish Journal of Clinical Pharmacology · 2026
7. Pharmacokinetics of Nirmatrelvir/Ritonavir after Multiple Administration in a Phase 1, Open-Label Study in Healthy Chinese Adults and Compared with Non-Chinese ParticipantsClinical Drug Investigation · 2026
8. Overcoming Immunotolerance in Chronic Hepatitis B: Efficacy of Granulocyte‐Macrophage Colony‐Stimulating Factor–Based Immunotherapy in Achieving Hepatitis B Surface Antigen SeroclearanceMedComm · 2026
9. Effectiveness of 13-valent Pneumococcal Conjugate Vaccine against Vaccine-type Invasive Pneumococcal Disease in Children under 5 Years Old in Zhejiang, China: a case-control studyInternational Journal of Infectious Diseases · 2026
10. Clinical implications of prostate specific antigen (PSA) flare and response dynamics in TALAPRO-2: A post-hoc analysis.Journal of Clinical Oncology · 2026
11. Real-world usage, effectiveness, and microbiological features of ceftazidime-avibactam in clinical practice in ChinaFrontiers in Cellular and Infection Microbiology · 2026
12. Pharmacokinetics of Aztreonam–Avibactam After Single‐ and Multiple‐Dose Administration: A Phase 1, Open‐Label Study in Healthy Chinese Participants and Ethnic Comparison with Non‐Chinese ParticipantsClinical Pharmacology in Drug Development · 2026
13. Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia AreataThe Journal of Dermatology · 2026
14. Patient preference for first-line treatments of ALK-positive metastatic non-small cell lung cancer: a discrete choice experimentBMC Cancer · 2026
15. Real-world use of and clinical outcomes with dacomitinib as first-line therapy in Asian patients with EGFR mutation–positive locally advanced or metastatic non-small cell lung cancer: Final analysis of the ARIA studyLung Cancer · 2025
16. Concordance in assessments between investigators and blinded independent central review (BICR) in hematology oncology clinical trials: a meta-analysisThe Oncologist · 2025
17. A User‐Centric Comprehension Assessment of Prescription Drug Package Inserts in China: A Cross‐Sectional StudyHealth Science Reports · 2025
18. Concordance in assessments between investigators and blinded independent central review (BICR) in hematology oncology clinical trials: a meta-analysisThe Oncologist · 2025
19. A Phase 1 Open‐Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Intranasal Dose of Zavegepant in Healthy Chinese AdultsClinical Pharmacology in Drug Development · 2025
20. Effectiveness and impact of 7 and 13-valent pneumococcal conjugate vaccines in Chinese children: A systematic review and meta-analysisHuman Vaccines & Immunotherapeutics · 2025